Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculations

Molecular BioSystems

Volumn 8, Issue 9, 2012, Pages 2260-2273

  Xu, Lei ^a   Li, Youyong ^a   Li, Lin ^a   Zhou, Shunye ^a   Hou, Tingjun ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRAZONE DERIVATIVE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR DYNAMICS; PROTEIN BINDING; THERMODYNAMICS;

HYDRAZONES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; THERMODYNAMICS;

EID: 84864672616     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c2mb25146a     Document Type: Article

References (52)

1. E. F. Morand M. Leech B. Jurgen MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis Nat. Rev. Drug Discovery 2006 5 399 410
2. E. Sanchez L. M. Gomez M. A. Lopez-Nevot M. A. Gonzalez-Gay J. M. Sabio N. Ortego-Centeno E. de Ramon J. M. Anaya M. F. Gonzalez-Escribano B. P. Koeleman J. Martin Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus Genes and Immunity 2006 7 433 436
3. F. G. Brown D. J. Nikolic-Paterson P. A. Hill N. M. Isbel J. Dowling C. M. Metz R. C. Atkins Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis J. Am. Soc. Nephrol. 2002 13 S7 S13
4. N. Yabunaka J. Nishihira Y. Mizue M. Tsuji M. Kumagai Y. Ohtsuka M. Imamura M. Asaka Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes Diabetes Care 2000 23 256 258
5. A. Zernecke C. Weber Chemokines in the vascular inflammatory response of atherosclerosis Cardiovasc. Res. 2010 86 192 201
6. M. Emonts F. C. G. J. Sweep N. Grebenchtchikov A. Geurts-Moespot M. Knaup A. L. Chanson V. Erard P. Renner P. W. M. Hermans J. A. Hazelzet T. Calandra Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis Clin. Infect. Dis. 2007 44 1321 1328
7. Y. Mizue S. Ghani L. Leng C. McDonald P. Kong J. Baugh S. J. Lane J. Craft J. Nishihira S. C. Donnelly Z. Zhu R. Bucala Role for macrophage migration inhibitory factor in asthma Proc. Natl. Acad. Sci. U. S. A. 2005 102 14410 14415
8. S. C. Donnelly C. Haslett P. T. Reid I. S. Grant W. A. H. Wallace C. N. Metz L. J. Bruce R. Bucala Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome Nat. Med. 1997 3 320 323
9. K. L. Meyer-Siegler K. A. Iczkowski L. Leng R. Bucala P. L. Vera Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells J. Immunol. 2006 177 8730 8739
10. T. Hagemann S. C. Robinson R. G. Thompson K. Charles H. Kulbe F. R. Balkwill Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis Mol. Cancer Ther. 2007 6 1993
11. R. Bucala S. C. Donnelly Macrophage migration inhibitory factor: A probable link between inflammation and cancer Immunity 2007 26 281 285
12. B. E. Rendon S. S. Willer W. Zundel R. A. Mitchell Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation Exp. Mol. Pathol. 2009 86 180 185
13. H. Sugimoto M. Taniguchi A. Nakagawa I. Tanaka M. Suzuki J. Nishihira Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 angstrom resolution Biochemistry 1999 38 3268 3279
14. E. Rosengren P. Aman S. Thelin C. Hansson S. Ahlfors P. Bjork L. Jacobsson H. Rorsman The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase FEBS Lett. 1997 417 85 88
15. R. Kleemann A. Kapurniotu R. W. Frank A. Gessner R. Mischke O. Flieger S. Juttner H. Brunner J. Bernhagen Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase J. Mol. Biol. 1998 280 85 102
16. J. B. Lubetsky M. Swope C. Dealwis P. Blake E. Lolis Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity Biochemistry 1999 38 7346 7354
17. M. Swope H. W. Sun P. R. Blake E. Lolis Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor EMBO J. 1998 17 3534 3541
18. K. Bendrat Y. Al-Abed D. J. E. Callaway T. Peng T. Calandra C. N. Metz R. Bucala Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor Biochemistry 1997 36 15356 15362
19. L. Leng C. N. Metz Y. Fang J. Xu S. Donnelly J. Baugh T. Delohery Y. B. Chen R. A. Mitchell R. Bucala MIF signal transduction initiated by binding to CD74 J. Exp. Med. 2003 197 1467 1476
20. X. R. Shi L. Leng T. Wang W. K. Wang X. Du J. Li C. McDonald Z. Chen J. W. Murphy E. Lolis P. Noble W. Knudson R. Bucala CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex Immunity 2006 25 595 606
21. J. Bernhagen R. Krohn H. Lue J. L. Gregory A. Zernecke R. R. Koenen M. Dewor I. Georgiev A. Schober L. Leng T. Kooistra G. Fingerle-Rowson P. Ghezzi R. Kleemann S. R. McColl R. Bucala M. J. Hickey C. Weber MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment Nat. Med. 2007 13 587 596
22. J. Garai T. Lorand Macrophage Migration Inhibitory Factor (MIF) Tautomerase Inhibitors as Potential Novel Anti-Inflammatory Agents: Current Developments Curr. Med. Chem. 2009 16 1091 1114
23. J. B. Lubetsky A. Dios J. L. Han B. Aljabari B. Ruzsicska R. Mitchell E. Lolis Y. Al-Abed The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents J. Biol. Chem. 2002 277 24976 24982
24. P. D. Senter Y. Al-Abed C. N. Metz F. Benigni R. A. Mitchell J. Chesney J. L. Han C. G. Gartner S. D. Nelson G. J. Todaro R. Bucala Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites Proc. Natl. Acad. Sci. U. S. A. 2002 99 144 149
25. D. R. Dabideen K. F. Cheng B. Aljabari E. J. Miller V. A. Pavlov Y. Al-Abed Phenolic hydrazones are potent inhibitors of macrophage migration inhibitory factor proinflammatory activity and survival improving agents in sepsis J. Med. Chem. 2007 50 1993 1997
26. G. A. Kaminski R. A. Friesner J. Tirado-Rives W. L. Jorgensen Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides J. Phys. Chem. B 2001 105 6474 6487
27. T. A. Soares D. S. Goodsell R. Ferreira A. J. Olson J. M. Briggs Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism J. Mol. Recognit. 2000 13 146
28. J. M. Wang R. M. Wolf J. W. Caldwell P. A. Kollman D. A. Case Development and testing of a general amber force field J. Comput. Chem. 2004 25 1157 1174
29. Y. Duan C. Wu S. Chowdhury M. C. Lee G. Xiong W. Zhang R. Yang P. Cieplak R. Luo T. Lee A point-harge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations J. Comput. Chem. 2003 24 1999 2012
30. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgomery, Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. G. Johnson, W. Chen, M. W. Wong, C. Gonzalez and J. A. Pople, GAUSSIAN 03, Gaussian, Inc., Wallingford, CT, 2004
31. C. I. Bayly P. Cieplak W. D. Cornell P. A. A. Kollman Well-Behaved Electrostatic Potential Based Method Using Charge Restraints for Deriving Atomic Charges - the Resp Model J. Phys. Chem. 1993 97 10269 10280
32. T. Darden D. York L. Pedersen Particle Mesh Ewald - an N.Log(N) Method for Ewald Sums in Large Systems J. Chem. Phys. 1993 98 10089 10092
33. J. P. Ryckaert G. Ciccotti H. J. C. Berendsen Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of N-Alkanes J. Comput. Phys. 1977 23 327 341
34. D. A. Case T. E. Cheatham T. Darden H. Gohlke R. Luo K. M. Merz A. Onufriev C. Simmerling B. Wang R. J. Woods The Amber biomolecular simulation programs J. Comput. Chem. 2005 26 1668 1688
35. P. A. Kollman I. Massova C. Reyes B. Kuhn S. H. Huo L. Chong M. Lee T. Lee Y. Duan W. Wang O. Donini P. Cieplak J. Srinivasan D. A. Case T. E. Cheatham Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models Acc. Chem. Res. 2000 33 889 897
36. J. M. Wang T. J. Hou X. J. Xu Recent advances in free energy calculations with a combination of molecular mechanics and continuum models Curr. Comput.-Aided Drug Des. 2006 2 287 306
37. T. J. Hou J. Wang Y. Y. Li W. Wang Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking J. Comput. Chem. 2011 32 866 877
38. T. J. Hou J. Wang Y. Y. Li W. Wang Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations J. Chem. Inf. Model. 2011 51 69 82
39. T. J. Hou R. Yu Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: Mechanism for binding and drug resistance J. Med. Chem. 2007 50 1177 1188
40. T. J. Hou W. Zhang X. J. Xu Binding affinities for a series of selective inhibitors of gelatinase-A using molecular dynamics with a linear interaction energy approach J. Phys. Chem. B 2001 105 5304 5315
41. T. J. Hou L. L. Zhu L. R. Chen X. J. Xu Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies J. Chem. Inf. Model. 2003 43 273 287
42. S. H. Huo J. M. Wang P. Cieplak P. A. Kollman I. D. Kuntz Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: Insight into structure-based ligand design J. Med. Chem. 2002 45 1412 1419
43. B. Kuhn P. A. Kollman Binding of a diverse set of ligands to avidin and streptavidin: An accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models J. Med. Chem. 2000 43 3786 3791
44. C. S. Page P. A. Bates Can MM-PBSA calculations predict the specificities of protein kinase inhibitors? J. Comput. Chem. 2006 27 1990 2007
45. J. M. Wang P. Morin W. Wang P. A. Kollman Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA J. Am. Chem. Soc. 2001 123 5221 5230
46. A. Onufriev D. Bashford D. A. Case Exploring protein native states and large-scale conformational changes with a modified generalized born model Proteins: Struct., Funct., Bioinf. 2004 55 383 394
47. J. Weiser P. S. Shenkin W. C. Still Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) J. Comput. Chem. 1999 20 217 230
48. T. J. Hou Z. Xu W. Zhang W. A. McLaughlin D. A. Case Y. Xu W. Wang Characterization of Domain-Peptide Interaction Interface: a generic structure-based model to decipher the binding specificity of SH3 domains Mol. Cell. Proteomics 2008 8 639 649
49. T. J. Hou W. Zhang D. A. Case W. Wang Characterization of domain-peptide interaction interface: A case study on the amphiphysin-1 SH3 domain J. Mol. Biol. 2008 376 1201 1214
50. H. Gohlke C. Kiel D. A. Case Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RaIGDS complexes J. Mol. Biol. 2003 330 891 913
51. T. Hou W. A. McLaughlin W. Wang Evaluating the potency of HIV-1 protease drugs to combat resistance Proteins: Struct., Funct., Bioinf. 2008 71 1163 1174
52. H. A. Carlson J. A. McCammon Accommodating protein flexibility in computational drug design Mol. Pharmacol. 2000 57 213 218